<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page26.png"">
<div class="txt" style="position:absolute; left:253px; top:89px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Ministry of Health - MS</span></div>
<div class="txt" style="position:absolute; left:196px; top:103px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">National Health Surveillance Agency </span><span class="f2" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">– </span><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ANVISA</span></div>
<div class="txt" style="position:absolute; left:144px; top:131px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">VI - flow diagram containing the steps of the manufacturing process of the</span></div>
<div class="txt" style="position:absolute; left:84px; top:146px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">medical device with a description of each step of the process, until the finished</span></div>
<div class="txt" style="position:absolute; left:84px; top:160px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">product is obtained, with the indication of the manufacturing units and their</span></div>
<div class="txt" style="position:absolute; left:84px; top:175px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">respective stages;</span></div>
<div class="txt" style="position:absolute; left:144px; top:197px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">VII - description of the safety and performance of the medical device, in</span></div>
<div class="txt" style="position:absolute; left:84px; top:212px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">accordance with the current regulation providing for the essential safety and</span></div>
<div class="txt" style="position:absolute; left:84px; top:227px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">performance requirements of medical devices.</span></div>
<div class="txt" style="position:absolute; left:144px; top:249px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 1 The proof of the safety and performance of the medical device must</span></div>
<div class="txt" style="position:absolute; left:84px; top:263px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">meet the requirements set out in applicable technical standards.</span></div>
<div class="txt" style="position:absolute; left:144px; top:285px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 2 If necessary, the health authority may request additional information or</span></div>
<div class="txt" style="position:absolute; left:84px; top:300px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">clarifications, as well as presentation of additional documentation, including a clinical</span></div>
<div class="txt" style="position:absolute; left:84px; top:315px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">study report specifically designed and conducted for investigation of the medical device</span></div>
<div class="txt" style="position:absolute; left:84px; top:330px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">subject to interest.</span></div>
<div class="txt" style="position:absolute; left:144px; top:351px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 58. The information of the Technical Dossier shall be organized</span></div>
<div class="txt" style="position:absolute; left:84px; top:366px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">according to the health risk class of the product, as set out in Annex II to this Resolution.</span></div>
<div class="txt" style="position:absolute; left:262px; top:388px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">CHAPTER VIII FINAL</span></div>
<div class="txt" style="position:absolute; left:203px; top:411px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">PROVISIONS AND TRANSITÓRIAS</span></div>
<div class="txt" style="position:absolute; left:144px; top:432px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 59. The notification regime applies the same types of health violations</span></div>
<div class="txt" style="position:absolute; left:84px; top:447px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">and the associated actions in force for the registration regime</span></div>
<div class="txt" style="position:absolute; left:84px; top:462px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">of medical devices.</span></div>
<div class="txt" style="position:absolute; left:144px; top:483px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 60. The notifications and records of medical devices, their changes and</span></div>
<div class="txt" style="position:absolute; left:84px; top:498px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">other acts will be published in the Official Gazette and will remain available for</span></div>
<div class="txt" style="position:absolute; left:84px; top:513px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">consultation on the electronic portal of Anvisa.</span></div>
<div class="txt" style="position:absolute; left:144px; top:535px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 1 Products subject to notification and registration may only be</span></div>
<div class="txt" style="position:absolute; left:84px; top:550px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">industrialized, imported, exposed for sale or delivered to consumption after the</span></div>
<div class="txt" style="position:absolute; left:84px; top:564px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">publication of the said notification or registration number.</span></div>
<div class="txt" style="position:absolute; left:144px; top:587px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 2 Products manufactured in national territory exclusively for export</span></div>
<div class="txt" style="position:absolute; left:84px; top:602px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">purposes do not require notification or registration with Anvisa.</span></div>
<div class="txt" style="position:absolute; left:144px; top:624px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 61. Protocols of medical device registration petitions will be accepted</span></div>
<div class="txt" style="position:absolute; left:84px; top:638px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">with the structuring of a technical report provided for in the Resolution of the</span></div>
<div class="txt" style="position:absolute; left:84px; top:653px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Collegiate Board of Directors - RDC No. 185, of October 22, 2001, protocolized until</span></div>
<div class="txt" style="position:absolute; left:84px; top:668px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">February 28, 2023.</span></div>
<div class="txt" style="position:absolute; left:144px; top:690px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Single paragraph. For records granted during the term of RDC No. 185, of</span></div>
<div class="txt" style="position:absolute; left:84px; top:704px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">October 22, 2001, the maintenance of the structuring of technical report will be</span></div>
<div class="txt" style="position:absolute; left:84px; top:719px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">allowed until possible request for change of approval registration required, which</span></div>
<div class="txt" style="position:absolute; left:84px; top:734px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">should include the new structure of Technical Dossier.</span></div>
<div class="txt" style="position:absolute; left:145px; top:782px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);">This text does not replace the published in the Official Gazette.</span></div>
</body>
</html>
